Patent details

EP3016954 Title: CRYSTALLINE FORMS OF PONATINIB HYDROCHLORIDE

Basic Information

Publication number:
EP3016954
PCT Application Number:
EP2014064358
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP147359665
PCT Publication Number:
WO2015001098
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
CRYSTALLINE FORMS OF PONATINIB HYDROCHLORIDE
French Title of Invention:
FORMES CRISTALLINES DU CHLORHYDRATE DE PONATINIB
German Title of Invention:
KRISTALLINE FORMEN VON PONATINIB HYDROCHLORID
SPC Number:

Dates

Filing date:
04/07/2014
Grant date:
31/10/2018
EP Publication Date:
11/05/2016
PCT Publication Date:
08/01/2015
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
31/10/2018
EP B1 Publication Date:
31/10/2018
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
04/07/2019
Expiration date:
04/07/2034
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
24/10/2018
 
 

Name:
Sandoz AG
Address:
Lichtstrasse 35, 4056 Basel, Switzerland (CH)

Inventor

1

Name:
SUNKARA, Asha
Address:
United Kingdom (GB)

2

Name:
REECE, Hayley
Address:
United Kingdom (GB)

3

Name:
STEFINOVIC, Marijan
Address:
Austria (AT)

Priority

1

Priority Number:
13175184
Priority Date:
04/07/2013
Priority Country:
European Patent Office (EPO) (EP)

2

Priority Number:
13188348
Priority Date:
11/10/2013
Priority Country:
European Patent Office (EPO) (EP)

Classification

IPC classification:
A61K 31/55; A61P 35/00; C07D 487/04;

Publication

European Patent Bulletin

Issue number:
201844
Publication date:
31/10/2018
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages